EUVIMEDEUVIMED entdecken
Crossref

Integrating diffusion-weighted imaging parameters with RECIST 1.1 for early assessment of systemic therapy response in lung cancer pelvic bone metastases

Hyemin Park iD, Seungeun Lee iD, So-Yeon Lee iD, Sungwon Lee iD, Joon-Yong Jung iD

British Journal of Radiology · 19.10.2026

DOI: 10.1093/bjr/tqag249 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Radiology, online erschienen am 19.10.2026. Verfasst von Hyemin Park und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. Die Arbeit nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To determine preliminary quantitative ADC thresholds for functional response and to evaluate whether integrating DWI metrics with RECIST 1.1 provides complementary information for early systemic therapy response assessment in bone metastases.

Methods

This retrospective single-center study included lung cancer patients with pelvic bone metastases who underwent 3 MRIs between November 2015 and November 2023: baseline, early time point (<4 months, TP1), and late (6-15 months, TP2) time points. ROC analysis based on lesion size change at TP2 determined ADC thresholds defining DWI response. A DWI response was defined as ADC > 1300 µm2/s or ΔADC > 0.14. An integrated response scheme (DWI-RECIST) combined this DWI-based response with RECIST assessment. Early responses at TP1 were compared between RECIST and DWI-RECIST using RECIST at TP2 as reference standard. Interobserver agreement was assessed using intraclass correlation coefficient, and diagnostic performance was evaluated using net reclassification improvement and AUCs.

Results

Seventy-eight lesions from 27 patients were included. Compared with RECIST, DWI-RECIST yielded net classification gains of 7.4% (reader 1) and 11.1% (reader 2). DWI-RECIST showed higher AUCs than RECIST (reader 1: 0.6964 vs. 0.6184, P = .472; reader 2: 0.6415 vs. 0.6184, P = .781). Interobserver agreement for ADC was good (ICC 0.83-0.86).

Conclusions

Integrating ADC-derived DWI metrics with RECIST 1.1 may provide complementary information for early assessment of pelvic bone metastases from lung cancer, particularly in lesions categorized as stable disease. Advances in knowledge This pilot study proposes quantitative ADC thresholds and introduces a framework integrating these with RECIST 1.1 to support more objective response assessment in lung cancer pelvic bone metastases.

Schlagwörter

Stichwörter der Autor:innen

DWIRECISTbone metastasisearly systemic therapy response evaluation

Autor:innen und Institutionen

  • Department of Radiology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

ORCID-Profile: Hyemin Park, Seungeun Lee, So-Yeon Lee, Sungwon Lee, Joon-Yong Jung

Zitieren

APA

Park, H., Lee, S., Lee, S. Y., Lee, S., & Jung, J. Y. (2026). Integrating diffusion-weighted imaging parameters with RECIST 1.1 for early assessment of systemic therapy response in lung cancer pelvic bone metastases. British Journal of Radiology. https://doi.org/10.1093/bjr/tqag249

Vancouver

Park H, Lee S, Lee SY, Lee S, Jung JY. Integrating diffusion-weighted imaging parameters with RECIST 1.1 for early assessment of systemic therapy response in lung cancer pelvic bone metastases. British Journal of Radiology. 2026. doi:10.1093/bjr/tqag249

BibTeX
@article{Park2026,
  author = {Park, Hyemin and Lee, Seungeun and Lee, So-Yeon and Lee, Sungwon and Jung, Joon-Yong},
  title = {Integrating diffusion-weighted imaging parameters with RECIST 1.1 for early assessment of systemic therapy response in lung cancer pelvic bone metastases},
  journal = {British Journal of Radiology},
  year = {2026},
  doi = {10.1093/bjr/tqag249}
}
Kostenlos starten →